Walgreens installing IoT voice technology in all U.S. stores

Walgreens store associates and managers across the U.S. will soon be equipped with small, AI-powered devices that will allow them to remain “heads-up and hands-free” while communicating among themselves to help customers.

The voice-controlled devices are intelligent IoT gadgets supplied by the mobile voice-tech company Theatro.

In announcing the installation, Dallas-based Theatro said an initial 1,000 stores will have the devices this year and the rest of Walgreens’ 9,560 stores will follow later.

Theatro’s voice platform for retail includes apps with self-explanatory names like Register Backup, Morning Huddle, Price Checks and Inventory Lookups.

Along with facilitating communications within Walgreens store teams, the technology will allow store managers to track performance metrics and identify areas in need of improvement, according to the announcement.

“As we transform our stores into modern neighborhood health destinations, it’s critical that we enable our store teams to enhance the experience for customers and patients,” said Richard Ashworth, the retail giant’s president of operations.

The move continues the march of Walgreens, like its competitor CVS—and newcomer Amazon PillPack—deeper into the age of digital medicine.

Last summer Walgreens announced the launch of Find Care Now, a digital platform and marketplace designed to connect mobile and web customers to various healthcare services beyond prescriptions and OTC remedies.  

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.